Advertisement
Home 2019 January

Monthly Archives: January 2019

Trained alert dogs can help patients with type 1 diabetes regulate their blood glucose levels

Trained Alert Dogs Can Detect Impending T1DM-Related Events

0
In study, individual dogs' performance varied for detecting hypoglycemic episodes, hyperglycemia
For asymptomatic patients with stable ischemic heart disease and coronary artery disease

Variation in Revascularization for Asymptomatic SIHD Unexplained

0
Consistent benefit observed for patients with stable ischemic heart disease managed by revascularization
Less than half of all outpatient antibiotic prescription fills by privately insured nonelderly adults and children in the United States are appropriate or potentially appropriate

Inappropriate Antibiotic Rx Common in Privately Insured

0
Only 12.8 and 35.5 percent of fills were appropriate, potentially appropriate in outpatients
Use of the oral hepatoselective glucokinase activator TTP399 for type 2 diabetes does not cause hypoglycemia and has no detrimental effect on plasma lipids or liver enzymes

Oral Hepatoselective Glucokinase Activator Promising in T2DM

0
Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399
U.S. states with more physicians and a larger percentage of non-Hispanic whites have worse melanoma survival

Melanoma Survival Varies Among U.S. States

0
Worse survival in states with more physicians; higher death rates in states with lower incidence
Mandated neonatal abstinence syndrome surveillance and reporting allows state health departments to quantify incidence and informs programs and services

Mandated Neonatal Abstinence Reporting Helps Quantify Cases

0
Five of six states with mandatory reporting receive case reports within 30 days of diagnosis
Radiographic knee osteoarthritis is associated with an increased risk for mortality from cardiovascular disease

Radiographic Knee Osteoarthritis Tied to Increased Risk for Death

0
Risk higher for cardiovascular disease, diabetes, renal mortality; lower risk for cancer mortality
Vaccine hesitancy is among the top 10 health threats facing the world in 2019

WHO: Vaccine Hesitancy a Major Global Health Threat

0
Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001
Due to the federal government shutdown

FDA Down to 5 Weeks of Funding to Review New Drug Applications

0
Agency cannot accept new fees or applications until the shutdown is over
The first generic version of Sabril (vigabatrin) has been approved by the U.S. Food and Drug Administration to prevent complex partial seizures in adults and children aged 10 years and older with epilepsy.

FDA Approves First Generic Version of Epilepsy Drug Sabril

0
Generic equivalents held to same vigorous manufacturing standards as brand-name drugs